To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects
Clinical trial NCT02312973 · COMPLETED
Trial details
- NCT number
- NCT02312973
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-14
- Primary completion
- 2015-12-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.